InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,446.68
(
-1.37%
)
US TECH 100
18,282.40
(
-2.97%
)
Dow Jones
40,347.97
(
-1.21%
)
Brent Oil
80.05
(
0.09%
)
Bitcoin
64,481.71
(
-1.33%
)
Post# of 252774
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 45
Posts 4628
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: biopearl post# 113504

Thursday, 01/27/2011 6:32:58 PM

Thursday, January 27, 2011 6:32:58 PM

Post# of 252774
sanofi's manufacturing process defines the product. it's almost impossible to conceive that TEVA was able to duplicate the production process exactly. so while SNY must have standard manufacturing controls, production of a generic equivalent using a different manufacturing process should require added validation analysis
at least that is my take on it
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up